clinical trials

News

Roche expands phase 3 plans for Alzheimer's drug

Roche has added a phase 3 trial of trontinemab, hoping to show it can delay or prevent progression to Alzheimer's symptoms in preclinical patients.

R&D

Evolution Summit 2025 Returns to San Diego promo image

Partner Content

Revolutionising Clinical Trials: Evolution Summit 2025 Retur...

Marcus Evans is proud to announce the Evolution Summit September 2025, an exclusive, invitation-only event bringing together leading clinical trial executives, innovative suppliers

R&D

Q2 clinical trials round-up: April to June 2025

The second quarter of 2025 has seen a surge of clinical trial activity across the pharmaceutical and biotech landscape.

News

Scancell points to 'strong' melanoma vaccine data

Scancell has the results it was hoping for with its melanoma immunotherapy iSCIB1+ and is accelerating plans for a pivotal trial.

News

Survival data back Tagrisso's role in first-line lung cancer

Can survival data from the FLAURA2 trial of Tagrisso help AstraZeneca fend off a challenge from J&J's fast-growing rival in EGFR-mutated lung cancer?

News

Roche's COPD candidate fails a phase 3 readout

Roche gambled on an all-comer design for trials of its COPD candidate astegolimab, a move that may prove costly as it fails a phase 3 test.

Roche expands phase 3 plans for Alzheimer's drug

Revolutionising Clinical Trials: Evolution Summit 2025 Retur...

Q2 clinical trials round-up: April to June 2025

Scancell points to 'strong' melanoma vaccine data

Survival data back Tagrisso's role in first-line lung cancer

Roche's COPD candidate fails a phase 3 readout

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

clinical trials

Editor's Picks